• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

A Licensing Deal for All Seasons

Monday, June 03, 2024
Breakout Session
Business Development and Finance
29AB
Partnerships are always vital to our industry to help bring new therapies to patients, but they are watched especially closely when economic downturns close the IPO window. E&Y reported that while the biotech IPO market fell 93% from 2021, partnerships rose to a projected value of $132.1 billion in 2022, the third-highest total in the past decade. This diverse panel of experts will discuss the differences and similarities in best practices for partnerships both in the best of times, and in the worst of times. This will include reviewing the current landscape, exchanging advice, and discussing any changes to be ready for when the economy is on the rise again.
Moderator
Jonathan Grinstein, PhD
Senior Editor
Inside Precision Medicine
Speakers
Uneek Mehra
CHIEF FINANCIAL & BUSINESS OFFICER
4DMT
Kunal Patel, MS, MBA
VP of Business Development
Synthekine
Gavin Samuels, MD
Chief Business Officer
CinRx Pharma
Lesley Stolz
Vice President
Johnson & Johnson Innovation
Richard Wilson
Senior VP, Primary Focus Lead of Genetic Regulation
Astellas Gene Therapies
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS